Human immunodeficiency virus type 1 (HIV-1) non-B clade viral infections of the brain have not been studied to date. Among nine AIDS patients from Nairobi, Kenya, infected with HIV-1 A (N ϭ 5) or D (N ϭ 4) clade strains, brain-derived HIV-1 env sequences displayed greater evolutionary distance than B clade brain-derived viruses (P Ͻ 0.001). Similarly, molecular diversity between matched brain and spleen env clones was clade-dependent and concentrated in the hypervariable V4 region (P Ͻ 0.001), with phylogenetic clustering of sequences derived from the same organ. Brain-derived A and D clade sequences displayed significantly lower ratios of nonsynonymous/synonymous substitution rates (d N /d S ) compared to matched spleen-derived clones and brain-derived B clade viruses. Interclade recombination events were infrequently observed among the present env sequences. A chimeric virus containing the C2V3 region from an A clade brain-derived sequence preferentially used CD4 and CCR5 for infection. These findings demonstrate that differences in molecular diversity in brain-derived sequences were dependent on the individual clade and domain within the env gene, but both B and non-B clade brain-derived viruses exhibit a preference for CCR5 as a coreceptor.
INTRODUCTION
Like all lentiviruses, human immunodeficiency virus type 1 (HIV-1) is neurotropic, although the mechanisms by which the virus enters and infects the brain remain uncertain (reviewed in Johnson, 1998) . All previous studies of HIV-1 derived from the brain have examined B clade (subtype) viruses isolated from North American and European patients (Hughes et al., 1997; Li et al., 1991; Pang et al., 1991; Reddy et al., 1996) . B clade brain-derived HIV-1 is macrophage-tropic, which is largely dependent on viral utilization of the CCR5 chemokine receptor although other chemokine receptors have been implicated in HIV-1 neuropathogenesis (Alkhatib et al., 1996; Chan et al., 1999; Choe et al., 1996; Deng et al., 1996; Doranz et al., 1996; Dragic et al., 1996; Wang et al., 1999) . Previous studies showed sequence differences between matched brain-and different organderived HIV-1 env genes (Epstein et al., 1991; Hughes et al., 1997) with similar findings among other viral genes, including the tat , gag (Morris et al., 1999) , and pol (Wong et al., 1997) genes. Evolutionary diversity among HIV-1 sequences from different organs within the same individual is dependent on the gene being examined; env sequences tend to show the greatest diversity because of the increased susceptibility of env to differing selection influences (Morris et al., 1999) . Furthermore, it has been postulated that viral recombination may play a role in the development of sequence diversity (Morris et al., 1999; Neilson et al., 1999; Robertson et al., 1995a) . Studies examining blood-derived HIV-1 sequences have shown that a more aggressive disease course and advanced disease status are associated with increased molecular diversity (Markham et al., 1998; Nowak et al., 1991; Wolinsky et al., 1996) . The disease course among patients in sub-Saharan Africa and Southeast Asia may be more rapid than in North America or Western Europe, with shorter survival times and shorter intervals between seroconversion and the development of AIDS, depending on the HIV-1 clade (Kanki et al., 1999; McCutchan et al., 1996a; Poss and Overbaugh, 1999) . Similarly, HIV-1 env sequences from patients with HIV-1 associated dementia display higher levels of viral molecular diversity than nondemented AIDS patients (Kuiken et al., 1995; Power et al., 1994) . In the present study, the molecular features and coreceptor usage of brain-derived and matched spleen-derived env sequences from patients in Nairobi, Kenya, were examined, where several HIV-1 clades have been previously re-ported (Belda et al., 1997; Neilson et al., 1999; Robertson et al., 1995a) .
RESULTS
A total of 73 brain-and spleen-derived gp120 encoding sequences were obtained from nine patients (6-15 clones for each patient). HIV-1 clade categorization with the NCBI subtyping HIV-1 program revealed that four patients were infected with D clade viruses and five with A clade viruses (Table 1) . In all nine patients, clones from brain and spleen for each patient belonged to the same clade. A rooted neighbor-joining phylogenetic tree was constructed using these 73 sequences of deduced amino acid (aa) from the brain-and spleen-derived clones (Fig. 1) . These sequences were compared to prototypic B clade viruses, based on the V1-V5 region of gp120. Sequences from these three clades (A, D, and B) were grouped separately into three lineages with bootstrap resampling supporting the distinction of these clades (bootstrap value Ն 90%) ( Fig. 1) , which further confirmed the above subtyping result. The sequences from brain or spleen clustered together phylogenetically within individual patients with high bootstrap values (bootstrap support of Ն99%, except patient 75 with 82%), whether based on amino acid (Fig. 1 ) or nucleotide (data not shown) sequences. Moreover, this host-dependent clustering of sequences was also observed when discrete gp120 gene regions (V1, V2, C2, V3, C3, V4, C4, and V5) were compared (data not shown).
Although limited diversity among brain-derived B clade HIV-1 env sequences has been reported (Li et al., 1991; Pang et al., 1991; Reddy et al., 1996) , the extent of diversity within the gp120 fragment in the present non-Bclade-infected patients was examined by comparing multiple clones from brain and spleen (three to seven clones from each tissue). Brain-and spleen-derived sequences consistently clustered within individuals, tending toward the tissue of origin (Fig. 1) . Within individual patients, comparison of similarity among brain-derived clones ranged from 76.4 to 100% (mean Ϯ SEM, 93.088 Ϯ 7.156), while in spleen-derived samples sequence similarity ranged from 72.1 to 100% (mean Ϯ SEM, 95.215 Ϯ 3.431) when predicted amino acid differences were compared. However, the mean similarity was 86.426 Ϯ 6.042 (range 68.8 to 99.8%) when comparing matched brain to spleen sequences within individuals, which differed from the inter-brain or -spleen comparisons (P Ͻ 0.0001). These analyses also revealed limited diversity within multiple clones from the same tissue and that brain and spleen sequences were evolutionarily divergent, consistent with the previous reports (Epstein et al., 1991; Gartner et al., 1997; Korber et al., 1994; Li et al., 1991; Monken et al., 1995 Monken et al., , 1991 Power et al., 1994) . To determine which domain(s) within gp120 displayed the greatest divergence between brain-and spleen-derived sequences from the same patient, sequence diversity was compared for all nine patients ( Fig. 2A) . Within the V4 region, there was significantly greater diversity between brain and spleen among D clade viruses than among A clade viruses. Within the V3 region, the diversity within the D clade viruses was greater than within the A clade viruses, whereas within the V1 region diversity within the A clade viruses was greater than within the D clade viruses, although not statistically significant. These results suggested that selective pressures acting on discrete domains within the virus differed depending on the viral clade.
To compare evolutionary differences among A and D clade viruses derived from both brain and spleen, calculations of mean pairwise total distance (d) and synonymous (d s ) and nonsynonymous (d N ) substitution rates for the entire gp120 sequence were made (Nei and Gojobori, 1986 ) using the MEGA package (Kumar et al., 1993) and compared to prototype B clade brain-derived viruses ( Phylogenetic tree of multiple HIV-1 env (gp120) sequences from paired brain-and spleen-derived clones of nine patients (73 clones) compared to the prototypic B clade viruses. The tree was constructed based on the V1-V5 region (including extra 20-40 amino acids from both adjacent sides) of gp120 (approximately 400 aa) by neighbor-joining analysis with pairwise gap stripping and p-distance using the MEGA program (Kumar et al., 1993) . The number at each node indicates the bootstrap values as determined from 100 bootstrap resamplings. The scale for p-distance is indicated below. Con-A, -D, and -B indicate consensus sequences for clades A, D, and B obtained from the Los Alamos HIV Sequence Database (updated November 1999). The prototypic clade B viruses are GC, DS, KJ, and RC (Gartner et al., 1997) , JRFL, SF162, and YU-2 from brain-derived clones, ADA and BAL from reported M-tropic viruses, and NL4-3, HXB2, HAN, MN, SF2, and SF33 from reported T-tropic viruses. B and S indicate brain-and spleen-derived clones, together with patient number (#) in the present A and D clade sequences. CPZ-GAB was used as the outgroup to root the tree.
prototype B clade brain-derived viruses, in addition to previously reported B clade brain-derived sequences (for V1-V3 domains only) that were obtained by methods similar to those of the present study (Power et al., 1994 (Fig. 2B) . The nonsynonymous substitution distance was markedly increased for all viruses in the V1 and V5 hypervariable regions, whereas, within the V4 region, D clade sequences from both brain and spleen
FIG. 2. Divergence and nonsynonymous substitution rates in different gp120 domains from clade A and D viruses. (A)
Divergence between matched brain-and spleen-derived gp120 sequences in multiple regions that was dependent on viral clade in the V1, V3, and V4 domains. The sequences were aligned using the Clustal method with the residue identity weight table from DNAStar and then divided into segments as indicated in the figure below the line using HXB2 gp120 amino acid numbering. The divergence (%) (the proportion of different amino acids between two compared sequences) was calculated by the DNAStar program. The individual bars represent the mean diversity between matched brain-and spleen-derived sequences for each patient. An asterisk indicates a difference between the groups of A and D clade sequences (Student's t test, P Ͻ 0.001). (B) Nonsynonymous substitution rates (ϮSEM) (d N ) in different gp120 domains among brain-and spleen-derived clones from clade A, D, and B viruses. The B clade brain-derived virus group (B-Brain-1) includes GC, DS, KJ, and RC, JRFL, SF162, and YU-2 (see Fig. 1 for the source of the sequences). The second B clade brain sequence group (B-Brain-2) (V1-V3 only) includes sequences from five patients, previously reported (Power et al., 1994 . d N was calculated as previously reported (Nei and Gojobori, 1986) . The distance of each segment within a group was compared to the equivalent distance in the other groups to determine if they were significantly different. An asterisk indicated a difference between the groups (Tukey-Kramer, *P Ͻ 0.01 and **P Ͻ 0.001). displayed significantly increased d N rates compared to those of both B and A clade viruses. In contrast to the above domain-specific variation d N rates, the V2, C2, C3, and V5 regions in all viruses showed similar d N rates (Fig. 2B ), indicating interclade molecular variability existed but was dependent on specific domains within gp120.
Given the extent of diversity within the present sequences from A and D clade viruses and a previous report of a high frequency of recombination events in brain-derived viruses (Morris et al., 1999) , viral recombination was examined in the present A and D clone sequences. Nucleotide sequences from all patients were first subjected to the scanning for recombination with the NCBI subtyping HIV-1 program and further confirmed by bootscanning (Lole et al., 1999) , the maximum 2 method, and bootstrap testing (Robertson et al., 1995a; Smith, 1992) . NCBI subtyping detected occurrence of recombination in 37 out of 73 clones (50.7%). However, confirmatory methods revealed few recombination events: bootscanning, 9 clones (12.3%); maximum 2 and bootstrap, 1 clone (1.4%). Hence, recombination within gp120 was confirmed only in 1 of 73 clones, which was a brain-derived clone from patient 99 (clone B99-1), using multiple methods. Recombination occurred between A and D clade viruses, spanning the V1 and V2 regions (Fig. 3A) , but this recombination event was not confirmed in other brain-derived or the matched spleen-derived clones from the same patient, although NCBI subtyping or the genetic similarity plot (SimPlot) (Lole et al., 1999) showed a similar pattern (data not shown). To estimate the location of the apparent crossover site, bootscanning (Lole et al., 1999) was performed using A and D clade representative sequences and the B clade virus, HXB2, as an out-group sequence (Fig. 3B) . By the method of maximization of 2 (Robertson et al., 1995a; Smith, 1992) , the most likely breakpoints were located in 55-233 bp (Fig. 3C ). This recombination event was further confirmed by bootstrap testing by constructing separate phylogenetic trees of the resulting regions (with bootstrap support of Ն95%) when the B99-1 clone was compared to representative A and D clade viruses (Fig. 3D ), indicating that recombination occurred infrequently in this group of patients.
Analyses of amino acid sequence alignments revealed that the V1 region was highly divergent, as predicted from Fig. 2B , and displayed few conserved amino acids, but frequent deletions or insertions were observed (data not shown). In the V3 (Fig. 4A ) region, many residues were conserved either in all clades or within individual clade. There was a restricted position for amino acid insertion in both regions (positions 185-191 and 317-323 in HXB2 gp120 aa numbering) for the V2 and V3 regions, respectively. At several positions (302, 304, 306, and 309 in HXB2 gp120 aa numbering) within in the V3 region (Fig. 4A) , specific aas were highly conserved across all brain-derived viruses and were not consistently observed in the spleen-derived sequences. Like the V1 and V2 regions, V4 and V5 (data not shown) did not show any mutations that were clearly unique to brain-derived viruses. In addition, the present sequences revealed no differences in amino acid composition in terms of basic amino acid substitutions or in potential N-linked glycosylation sites, which have been reported to play a direct role in coreceptor specificity (Chesebro et al., 1996; Milich et al., 1997) and syncytia induction capacity (Groenink et al., 1993; Overbaugh and Rudensey, 1992) , respectively. To determine if previously reported mutations associated with macrophage tropism or CCR5 utilization were present in our brain-derived clones, we compared the present sequences to previous reports (Wang et al., 1999) . Few residues associated with CCR5 utilization were observed in the present A and D clade viruses (Fig.  4A) , suggesting that these mutations may not be required for macrophage tropism of A and D clade viruses.
The V3 hypervariable region of the gp120 env protein expresses the principal determinants of cell tropism (Chesebro et al., 1992 (Chesebro et al., , 1996 Hwang et al., 1991 West- Note.The d value was calculated from the J-C distance using the MEGA program (Kumar et al., 1993) , and d S and d N were estimated based on the method of Nei and Gojobori (1986) . See Fig. 1 (Lole et al., 1999) using A and D clade representative sequences and B clade virus HXB2 as an outgroup sequence. The scanning was performed with 100 bootstrap resamplings using a neighbor-joining method with Kimura two-parameter distance and the transition/transversion ratio of 1.3 from PHYLIP (Phylogeny Inference Package) version 3.5c (Felsenstein, 1995) . The gaps were stripped and window size was set at 180 bp with a step of 20 bp. The position was marked with the corresponding segments of gp120 and the numbering indicated below. (C) The maximum 2 : Informative sites were obtained from B and the maximum 2 was calculated as described (Robertson et al., 1995a; Smith, 1992) . (D) The bootstrap test was done with a neighbor-joining method with pairwise gap stripping and the J-C distance, using A, D, and B representative sequences as indicated in (B). The bootstrap values were indicated at node and the distance scale is shown for each individual tree. ervelt et al., 1992) and coreceptor use (Chan et al., 1999; Choe et al., 1996; Cocchi et al., 1996; Speck et al., 1997) . Transfer of a V3 loop from one virus into a distinct HIV-1 background typically retains the coreceptor usage profile of the V3 donor virus (Chan et al., 1999; Choe et al., 1996; Speck et al., 1997) . To explore the tropism of the current non-B clade viruses, we constructed chimeric viruses containing the C2V3 region (corresponding to 6825-7268 bp) derived from all patients' brain-and spleen-derived sequences, as well as from JRFL (as a positive control), in the genomic backbone of pNL4-3, which is T-tropic and preferentially uses CXCR4 chemokine receptor. A live chimeric virus was obtained, which replicated at similar levels to the parent virus in peripheral blood mononuclear cells (PBMCs) (data not shown). This chimeric virus contained an A clade brain-derived sequence (clone B118-1) from patient 118. To determine chemokine receptor utilization by this virus, a pseudotype luciferase reporter virus infection assay was carried out as previously described (Chan et al., 1999) . The A clade brain- (Power et al., 1994 and indicated at the top with HXB2 amino acid numbering. Consensus sequences for B, A, and D clade viruses were obtained from the Los Alamos HIV Sequence Database and indicated at the top for each group. The residues previously associated with CCR5 chemokine receptor utilization in the B clade virus are circled. The shaded amino acids were highly conserved across all brain-derived viruses but not consistently observed in the spleen-derived sequences. A solid box indicates the tetrametric tip of the V3 loop motif and dot boxes indicate the restricted position for amino acid insertion. Plasmids NL-B118 and NL-JRFL contain chimeric pNL4-3 provirus with a 443-bp insertion (StuI-NheI) that included the C2V3 region of the clade A brain-derived gp120 sequence of patient 118 (B118-1) or the JRFL gp120 sequence, respectively. Chemokine receptor utilization was assayed by a previously described luciferase reporter virus infection assay (Chan et al., 1999) derived chimeric virus (NL-B118) preferentially used CCR5 as a coreceptor (Fig. 4B) , but did not infect CXCR4- (Fig. 4C ) or CCR3- (Fig. 4D) expressing cells, similar to the prototype brain-derived B clade virus, JRFL. Chimeric viruses containing brain-derived sequences from three other patients (D clade, B75-1, and A clade, B99-1 and B104-5) were passaged repeatedly but replicated at low levels in PBMCs. These latter viruses also exhibited a preference for CCR5 as a coreceptor by infection of HeLa CD4/CXCR4/CCR5 or HeLa CD4/CXCR4 detected by p24 immunostaining (data not shown), indicating that infection of non-B clade viruses shared a similar cell tropism and chemokine coreceptor utilization in the brain to those of B clade HIV-1 strains.
DISCUSSION
The present studies represent several important findings, including: (1) marked differences in evolutionary parameters between sequences from different clades, which depended on the specific domains within env and the tissue from which the sequences were derived; (2) infrequent occurrence of viral recombination despite using rigorous methodologies and the increased potential of recombination because of the presence of multiple clades in this geographic region; and (3) evidence for CCR5 utilization by a brain-derived non-B clade recombinant virus. Earlier reports of B clade brain-derived HIV-1 env sequences revealed limited molecular variability compared to viral sequences from blood and spleen (Li et al., 1991; Pang et al., 1991; Power et al., 1994) . Of interest, V1-V3 sequences for both groups of B clade brain-derived clones demonstrated no major differences in molecular diversity despite different methods of virus isolation. Among the present brain-derived env sequences, A and D clade viruses were highly divergent, compared to B clade brain-derived viral sequences. In addition, D clade viruses showed greater evolutionary distances than the corresponding A clade sequences. A potential explanation for the increased diversity may be a difference in host-specific modulation of the selective constraints that drive viral gene evolution (Bagnarelli et al., 1999) , although the present patients were all AIDSdefined and from the same center. Since multiple HIV-1 clades are present in Nairobi, viral genetic diversity could also arise through recombination events (Hu and Temin, 1990; Katz and Skalka, 1990) . Proviral genomes that are mosaic over the length of the genome as well as recombinant forms of individual HIV-1 genes have been described (Carr et al., 1996; Cornelissen et al., 1996; Gao et al., 1996a,b; Leitner et al., 1995; Lole et al., 1999; McCutchan et al., 1996b; Robertson et al., 1995a,b) ; Salminen et al., 1997; Takehisa et al., 1999) . Neilson et al. (1999) detected 2.2% interclade recombinant env genes in Nairobi, Kenya, but they predicted that Ͼ20% of Kenyan HIV-1 proviral genomes would be interclade recombinants. However, the present studies detected one (1.4%) A and D interclade gp120 sequence among nine patients using multiple confirmatory methods. Detection of interclade recombinants only in brain implies that at some earlier time point the brain may have been coinfected with A and D clade viruses and recombination may have occurred within the brain. This supposition is supported by Morris et al. (1999) , who observed the mosaic structure of p17 gag , pol, hypervariable regions of gp120, and gp41/nef being assembled within brain from different combinations of evolutionarily distinct lineages in B clade virus. However, the possibility that recombination may have occurred outside brain prior to neuroinvasion must also be considered. Nonetheless, increased molecular diversity within brain-derived HIV-1 env sequences has been associated with the development of HIV dementia (Power et al., 1994) . In addition, greater viral molecular diversity has also been suggested as a determinant of systemic HIV-1 virulence (Markham et al., 1998; Wolinsky et al., 1996) , which may explain in part shorter survival times in sub-Saharan Africa, especially in persons infected with HIV-1 D clade viruses (Kanki et al., 1999) .
Selective pressures within the microenvironments of different anatomic compartments result in the emergence of dominant HIV-1 quasispecies (Bagnarelli et al., 1999; Wong et al., 1997) . The present study of A and D clade viruses showed that brain-and spleen-derived clones from the same patient differed significantly. Moreover, both A and D clade brain-derived sequences displayed lower d N /d S ratios compared to those of the corresponding spleen-derived viruses. These latter findings suggest that the effects of selective pressure may be less on brain-derived A or D clade viruses than on spleen-derived viruses (Bagnarelli et al., 1999) , perhaps due to the brain being a relatively immunologically isolated compartment (Streilein and Taylor, 1997) . The extent of sequence divergence between brain-and spleenderived sequences differed depending on the domain within gp120 and the individual viral clade. For example, within the V4 and V3 regions, there was greater diversity between brain and spleen among D clade viruses than among A clade viruses, while the converse was true for the V1 region, where the diversity within the A clade sequences were greater than within the D clade. This result underscores Ping et al.'s finding (1999) , which indicated that the V3 region of the X4-like B clade sequences was significantly more variable than the V3 region of the B clade R5-like sequences (with similar variability in other regions for both groups), whereas the subtype C sequences in the V4 region exhibited significantly greater variability than comparable sequences from clade B viruses. Together, these data suggest that discrete domains can be affected by selective pressures depending on the viral clade and coreceptor preference.
Brain or spleen tissue-specific signature sequences in the present A and D clade viruses could not be identified, despite previous reports of brain-specific sequences (Korber et al., 1994) . The survival of patients infected with HIV-1 B clade virus in North America and Europe is estimated to be 10-15 years (O'Brien et al., 1996) , whereas survival time and the time to AIDS development in Africa is shorter (Del Amo et al., 1998; Kanki et al., 1999; Robinson and Marindo, 1999; Spira et al., 1999; Timaeus, 1998) ; thus, perhaps not enough time had elapsed for A and D clade viruses to evolve tissuespecific signature sequences, as suggested by other previous studies (Gartner et al., 1997; Nowak et al., 1991; Wolinsky et al., 1996) . A single chimeric virus was obtained from the present non-B clade sequences that replicated at high levels in PBMCs. However, utilization of CCR5 as a coreceptor by this A clade brain-derived chimeric virus suggests that infection of A clade viruses may share similar cell tropism and chemokine coreceptor utilization in the brain to those of B clade HIV-1 strains (Chan et al., 1999; Power et al., 1998) . Nonetheless, brain-derived chimeric viruses from three other patients replicated at low levels, possibly due to incompatability between non-B clade sequences with NL4-3, despite exhibiting a preference for CCR5 as a coreceptor. The low levels of infection by these latter recombinant viruses may also reflect properties of brain-derived viruses, which tend to replicate at lower levels that the parent T cell tropic viruses or Mtropic viruses derived from organs other than brain (Chesebro et al., 1992; Ohagen et al., 1999; Power et al., 1995) .
MATERIALS AND METHODS

Subject and frozen tissues
Frozen brain and spleen were obtained at autopsy with consent as part of a prospective study of HIV-1 seropositive adult patients with AIDS admitted to Kenyatta National Hospital in Nairobi, Kenya (Rana et al., 2000) . Nine patients were included in this study and their general autopsy findings and clinical features are summarized in Table 1 .
Nested PCR, molecular cloning, and sequencing
The complete env gene was amplified directly from genomic DNA and extracted with DNAzol (GIBCO BRL) from matched brain and spleen samples in nine patients, using a nested PCR protocol (outer primers, 5Ј-AGA GCA GAA GAC AGT GGC AAT-3Ј and 5Ј-TTT TGA CCA CTT GCC ACC CAT-3Ј; inner primers, 5Ј-ATG AGA GTG AAG GGG ATA CAG AGG AAT-3Ј and 5Ј-TTA TAG GAA AGC CCT TTC TAA GCC CTG-3Ј, corresponding to HXB2 nucleotide position numbers 6206-6226, 8817-8797, 6225-6252, and 8795-8769, respectively) using Taq polymerase and AmpliWax PCR Gem 50 (Perkin-Elmer) according to the manufacturer's instructions. PCR products were purified using Gel Extraction Kit 150 (Qiagen) and then ligated into pcDNA3.1 using Eukaryotic TOPO TA cloning kit (Invitrogen). DNA sequencing was performed in both directions with internal primers spanning the V1-V5 regions of gp120, using ABI PRISM Big Dye Terminator Cycle Sequencing and ABI 373A automated sequencer (Applied Biosystems). Regions corresponding to the PCR amplification primers were excluded from the sequence analysis.
Sequence analyses
HIV-1 clade typing was performed with the NCBI Subtyping HIV-1 program (URL: http://www.ncbi.nlm.nih.gov) (the representative sequences were updated September, 2000) . The DNAStar software package (DNAStar Inc.) was used to align the sequences and determine the similarity and divergence among the sequences. Estimations of total distance and synonymous and nonsynonymous distances were based on the method of Nei and Gojobori (1986) . Phylogenetic and bootstrap analyses were carried out with the MEGA program (Kumar et al., 1993) . For analysis of evolutionary distance for the envelope segments, envelope sequences spanning V1 through V5 were aligned using Clustal method from DNAStar. The alignments were optimized manually to ensure that codons remained intact and gaps were minimized. Sequences were then divided into segments of around 25-50 codons, based on the location of hypervariable and conserved domains.
Recombination analyses
The sequences were first subjected to scanning for recombination with the NCBI subtyping HIV-1 program using the representative sequences from the program (to be updated September 2000) and the predefined HIV-1 subtype consensus sequences from the RIP program on the world wide web at URL http://hiv-web.lanl.gov (updated November 1999). The distance plot and bootscanning were performed using the SimPlot program (Lole et al., 1999) to identify informative sites and a cluster analysis maximizing the value of 2 (maximum 2 test) was then used to select crossover breakpoints (Robertson et al., 1995a; Smith, 1992) . These breakpoints were used to divide the alignment into segments for phylogenetic tree construction and the recombination event was further confirmed by bootstrap testing as described above.
Construction of chimeric proviruses and coreceptor utilization assay for single-round infection
Molecular clones pNL4-3 and pNL-Luc-E Ϫ R Ϫ (the NL4-3 provirus backbone with a luciferase reporter gene insertion) and cell lines expressing different chemokine receptors, HeLa-CD4/CXCR4 (Clone 1022), and human osteosarcoma Ghost-CD4/CXCR4/CCR3, were obtained from the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases. Plasmids NL-B118 and NL-JRFL containing chimeric NL4-3 provirus with a 443-bp insertion (StuI-NheI) that included the C2V3 region (corresponding to 6825-7268 bp in HXB2 numbering) of clade A of the brain-derived gp120 sequence of patient 118 (B118-1) or the JRFL gp120 sequence, respectively, were constructed as reported . Chemokine receptor utilization was assayed by a previously described luciferase reporter virus infection assay (Chan et al., 1999) . Briefly, chimeric virus and pNL-Luc-E Ϫ R Ϫ plasmids were transfected into 293T cells using CaPO4. Viral supernatants were harvested 2 days posttransfection, cleared of cell debris by low-speed centrifugation, and used to infect different cell lines expressing different chemokine receptors. Infection of target cells by pseudotyped virus led to expression of luciferase, which was quantified in cell lysates 2 days following addition of virus, using the Luciferase Assay Kit (PharMingen, Canada).
Statistical analysis
Statistical analyses were performed using Instat, Graphpad, for both parametric and nonparametric comparisons. P values of less than 0.05 were considered significant.
Nucleotide sequence Accession Numbers
The present nucleotide sequences have been submitted to GenBank.
